Supplementary Tables from Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer

Authors :: Alice T. Shaw
Aaron N. Hata
Ted W. Johnson
Jeffrey A. Engelman
Mari Mino-Kenudson
Jochen K. Lennerz
Cyril H. Benes
A. John Iafrate
Rebecca S. Heist
Daria Timonina
Krystina E. Kattermann
Amanda K. Riley
Lorin A. Ferris
Justin F. Gainor
Harper Hubbeling
Sergei Timofeevski
Ibiayi Dagogo-Jack
Kylie Prutisto-Chang
Leila Dardaei
Adam Langenbucher
Luc Friboulet
Benjamin J. Burke
Michael S. Lawrence
Jessica J. Lin
Satoshi Yoda
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: suppl tables

Full Text Access

Tools